Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02560103 · ClinicalTrials.gov registry record
An Observational Study to Investigate the Effects of Rapid Transmeridian Travel
A clinical trial of Jet Lag Disorder, sponsored by Vanda Pharmaceuticals.
- Completed
- Registry status
- 119
- Enrollment target
- 2
- Study locations
NCT02560103 is a study of Jet Lag Disorder that has completed, run by Vanda Pharmaceuticals. The registered enrollment target is 119 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT02560103, a study of Jet Lag Disorder, has completed, sponsored by Vanda Pharmaceuticals.
- COMPLETED
- Registry status
- 119 participants
- Enrollment target
- 2
- Study locations
Study Summary
Observational study to investigate circadian rhythm patterns
Conditions Studied
Interventions
- OTHER Transmeridian travel across multiple time zones
Study Locations (2)
California
- Santa Monica Clinical Trials - Santa Monica
Maryland
- The Center for Sleep & Wake Disorders - Chevy Chase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02560103
The ClinicalTrials.gov registry entry for NCT02560103 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanda Pharmaceuticals, which has 68 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Jet Lag Disorder appearing as the primary indexed condition, and to 1 intervention - of which Transmeridian travel across multiple time zones is the first listed.
NCT02560103 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Maryland.
Frequently Asked Questions
What is clinical trial NCT02560103 about?
NCT02560103 is a clinical study titled "An Observational Study to Investigate the Effects of Rapid Transmeridian Travel". Observational study to investigate circadian rhythm patterns
What is the current status of trial NCT02560103?
This trial is currently completed. The enrollment target is 119 participants. The study started on 2015-09. Estimated completion is 2017-10.
What conditions does trial NCT02560103 study?
This clinical trial studies the following conditions: Jet Lag Disorder.
What interventions are being tested in trial NCT02560103?
The interventions under investigation include: Transmeridian travel across multiple time zones (OTHER).
Who is sponsoring clinical trial NCT02560103?
This trial is sponsored by Vanda Pharmaceuticals, which has 68 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02560103 being conducted?
This trial has 2 study locations across California, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Jet Lag Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.